## Adenocarcinoma vs Large Cell Carcinoma: Key Discriminators ### Diagnostic Challenge **Key Point:** Large cell carcinoma (LCC) is defined as a NSCLC that lacks specific differentiation — it is a diagnosis of exclusion. Adenocarcinoma is distinguished by the presence of glandular structures and mucin production, which are absent in LCC by definition. ### Histological Comparison | Feature | Adenocarcinoma | Large Cell Carcinoma | |---------|---|---| | **Glandular structures** | Present (required for diagnosis) | Absent (excluded by definition) | | **Mucin production** | Present (mucicarmine/PAS+) | Absent | | **TTF-1** | Positive (70–80%) | Variable (40–50%) | | **Neuroendocrine markers** | Negative | Negative | | **p63/CK5/6** | Negative/weak | Negative | | **Keratin pearls** | Absent | Absent | | **Mitotic rate** | Moderate to high | Very high | | **Prognosis** | Better (stage-dependent) | Worse (aggressive) | ### Why Glandular Differentiation + Mucin is the Discriminator **High-Yield:** Large cell carcinoma is a diagnosis of exclusion — it is a poorly differentiated NSCLC that shows no squamous, glandular, or neuroendocrine differentiation. If you identify glandular structures and mucin production, the tumour is adenocarcinoma, not LCC. **Clinical Pearl:** Large cell carcinoma is rare (~10% of NSCLCs) and has a worse prognosis than adenocarcinoma because it lacks specific differentiation markers that guide targeted therapy. Adenocarcinoma, by contrast, can be tested for EGFR mutations, ALK rearrangement, and PD-L1 expression. ### Immunohistochemical Overlap **Warning:** TTF-1 can be positive in both adenocarcinoma and some large cell carcinomas (~40–50% of LCC). Negative p63/CK5/6 is seen in both. The defining feature is the presence or absence of glandular differentiation and mucin production. **Mnemonic:** **GLAD** — GLandular And Differentiation in adenocarcinoma (vs LCC, which lacks this). [cite:Robbins 10e Ch 15] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.